CDC signs off on Moderna, J&J boosters, backs mix ‘n’ match shots
Oct 22, 2021
The agency plans to release guidance early next week about who might benefit from choosing one booster over another.
FDA approves first RSV vaccine
May 03, 2023
Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.
FDA approval of new COVID-19 boosters could come by Friday
Sep 07, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
CDC panel gives support to new COVID-19 booster shots
Sep 13, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Which cancer patients need a COVID-19 booster shot most?
Sep 07, 2021
National Comprehensive Cancer Network Vaccination Advisory Committee guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines.
FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.